Thesefindings represent a promising starting point to further improve anddevelop this chemical class, adding a new chemotype to the existingclasses of CFTR potentiators, possibly expanding the current portfolioof therapeutic solutions for the treatment of CF. This evidence concerns the gene CFTR and cystic fibrosis.